Table 4.
Clinical status of antifungal drugs used in onychomycosis.
| Therapeutic agent | Clinical status | Reference |
|---|---|---|
| Amorolfine/RV4104A/Ciclopiroxolamine | Unknown | [25] |
| Econail™ (econazole) | Phase II (completed) | [26] |
| Phytonail/Loceryl | Unknown | [25] |
| Terbinafine hydrochloride/amorolfine | Completed | [25] |
| Terbinafine hydrochloride | Completed | [25] |
| Ciclopirox | Completed | [25] |
| Amorolfine/terbinafine | Completed | [25] |
| MycoVa™ | Phase III (completed) | [26] |
| Er:YAG laser (device) with amorolfine | Unknown | [25] |
| Luliconazole (solution) | Phase IIb/III (ongoing) | [25] |
| Efinaconazole (10% topical solution) | Phase III (completed) | [27] |
| TDT067 (liquid spray) | Phase III (ongoing) | [26] |
| P-3058 | Phase II (ongoing) | [26] |
| Isavuconazole | Phase III (completed) | [28] |
| Tavaborole | Phase III (completed) | [29] |
| Albaconazole | Phase II (completed) | [30] |
| Posaconazole | Phase II (completed) | [30] |
| VT-1161 | Phase II (ongoing) | [31] |